Fisher & Paykel Healthcare Corporation Limited (FPLB) Stock Statistics & Valuation Metrics

Fisher & Paykel Healthcare Corporation Limited has a market cap or net worth of EUR 14.09B. The enterprise value is EUR 21.78B.

Market Cap

EUR 14.09B

Enterprise Value

EUR 21.78B

Fisher & Paykel Healthcare Corporation Limited has 588,265,440 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

588,265,440

Owned by Insiders

0.17%

Owned by Institutions

15.35%

Fisher & Paykel Healthcare Corporation Limited’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 20.72%.

Return on Equity (ROE)

0.22

Return on Assets (ROA)

0.16

Return on Invested Capital (ROIC)

20.72%

Return on Capital Employed (ROCE)

0.28

Revenue Per Employee

316.25K

Profits Per Employee

63.35K

Employee Count

7,396

Asset Turnover

0.82

Inventory Turnover

2.56

The current PE Ratio of Fisher & Paykel Healthcare Corporation Limited is 59.57. Fisher & Paykel Healthcare Corporation Limited’s PEG ratio is 1.67.

PE Ratio

59.57

PS Ratio

11.97

PB Ratio

13.22

Price to FCF

57.08

Price to Operating Cash Flow

42.18

PEG Ratio

1.67

In the last 12 months, Fisher & Paykel Healthcare Corporation Limited had revenue of 2.34B and earned 468.50M in profits. Earnings per share was 0.80.

Revenue

2.34B

Gross Profit

1.50B

Operating Income

667.00M

Pretax Income

631.50M

Net Income

468.50M

EBITDA

825.60M

Earnings Per Share (EPS)

0.80

In the last 12 months, operating cash flow was 663.20M and capital expenditures -172.80M, giving a free cash flow of 490.40M billion.

Operating Cash Flow

663.20M

Free Cash Flow

490.40M

Free Cash Flow per Share

0.84

Fisher & Paykel Healthcare Corporation Limited pays an annual dividend of ―, resulting in a dividend yield of 1.52%

Dividend Per Share

―

Dividend Yield

1.52%

Payout Ratio

N/A

Free Cash Flow Yield

1.75%

Earnings Yield

1.67%

Beta

0.33

52-Week Price Change

31.49%

50-Day Moving Average

22.85

200-Day Moving Average

19.94

Relative Strength Index (RSI)

52.28

Average Volume (3m)

38

Fisher & Paykel Healthcare Corporation Limited upcoming earnings date is Nov 25, 2026, After Close (Not Confirmed).

Last Earnings Date

May 25, 2026

Next Earnings Date

Nov 25, 2026

Ex-Dividend Date

―

Fisher & Paykel Healthcare Corporation Limited as a current ratio of 2.31, with Debt / Equity ratio of 6.91%

Current Ratio

2.31

Quick Ratio

1.66

Debt to Market Cap

0.00

Net Debt to EBITDA

-0.38

Interest Coverage Ratio

64.76

In the past 12 months, Fisher & Paykel Healthcare Corporation Limited has paid 163.00M in taxes.

Income Tax

163.00M

Effective Tax Rate

0.26

Fisher & Paykel Healthcare Corporation Limited EV to EBITDA ratio is 33.89, with an EV/FCF ratio of 56.44.

EV to Sales

11.83

EV to EBITDA

33.89

EV to Free Cash Flow

56.44

EV to Operating Cash Flow

41.73

Fisher & Paykel Healthcare Corporation Limited has EUR 461.10M in cash and marketable securities with EUR 146.10M in debt, giving a net cash position of EUR 315.00M billion.

Cash & Marketable Securities

EUR 461.10M

Total Debt

EUR 146.10M

Net Cash

EUR 315.00M

Net Cash Per Share

EUR 0.54

Tangible Book Value Per Share

EUR 3.48

Gross margin is 64.16%, with operating margin of 28.52%, and net profit margin of 20.03%.

Gross Margin

64.16%

Operating Margin

28.52%

Pretax Margin

27.00%

Net Profit Margin

20.03%

EBITDA Margin

34.92%

EBIT Margin

28.14%

The average price target for Fisher & Paykel Healthcare Corporation Limited is EUR 25.82, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

EUR 25.82

Price Target Upside

8.51% Upside

Analyst Consensus

Strong Buy

Analyst Count

8

Revenue Growth Forecast

5.88%

EPS Growth Forecast

13.61%